HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Helena Rubenstein

This article was originally published in The Rose Sheet

Executive Summary

Cosmair division celebrates brand's re-entry into the U.S. market and the debut of its Soho, New York City flagship spa and retail store, the HR Beauty Gallery, April 8. The retail environment offers a full range of skin care and color cosmetic products - from masks and cleansers to black lipsticks and multi-colored glitter gels. Skin care formulations include Force C anti-aging products as well as Mat Specialist for oily skin and Hydro Urgency for dry skin. Highlights of the color collection include transfer-resistant Rouge Forever Tenacity Lipstick, transfer-resistant Spectacular Makeup SPF 10 foundation, Color Firmness Energizing Tinted Moisturizer SPF 12 with vitamin B and mineral salts. The four mascara formulas are Generous Thickening, Spectacular Lengthening, Vertiginous Curling and Long Lash Spike Effects

Latest Headlines
See All
UsernamePublicRestriction

Register

RS006531

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel